NCT07088471View on ClinicalTrials.gov

Cardiac Left Atrial Evaluation and Response in HFrEF With Sacubitril/Valsartan

Active, not recruitingOBSERVATIONAL
Enrollment

334

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

May 1, 2025

Study Completion Date

August 1, 2025

Conditions
Heart Failure and Reduced Ejection Fraction
Interventions
DRUG

Sacubtril/Valsartan

Angiotensin-receptor blocker and neprilysin inhibitor therapy

Trial Locations (1)

Unknown

Connoly Hospital Blanchardstown, Dublin

All Listed Sponsors
lead

Connolly Hospital Blanchardstown

OTHER

NCT07088471 - Cardiac Left Atrial Evaluation and Response in HFrEF With Sacubitril/Valsartan | Biotech Hunter | Biotech Hunter